Abstract | BACKGROUND:
Lectin-like oxidized LDL receptor-1 (LOX-1) was originally identified as a receptor expressed predominantly in endothelial cells. LOX-1 can also be expressed in other cell types, and the activation of the LOX-1 pathway has been implicated in apoptosis. There have been no reports, however, about LOX-1 expression in cardiac myocytes or regulation of myocardial cell apoptosis by LOX-1. METHODS AND RESULTS: In primary cardiac myocytes from neonatal rats, immunohistochemical analyses using a specific monoclonal antibody against LOX-1 demonstrated that LOX-1 expression was markedly induced by stimulation with norepinephrine and endothelin-1. LOX-1 expression was upregulated in cardiac myocytes as well as in vessel walls of failing rat hearts in vivo. In the presence of a low concentration of oxidized LDL that did not induce apoptosis by itself, artificial overexpression of LOX-1 in cardiac myocytes in culture resulted in apoptosis. LOX-1 overexpression induced activation of p38 mitogen-activated protein kinase (MAPK) and oxidative stress in cardiac myocytes, as demonstrated by an increase in positive immunostaining for 8-hydroxy-2'-deoxyguanosine. Inhibition of p38 MAPK by cotransfection of a dominant-negative form of MKK6 as well as by administration of a specific inhibitor, SB203580 or FR167653, almost completely blocked the induction of apoptosis by LOX-1 activation. Antioxidant catalase also blocked LOX-1-induced apoptosis as well as activation of p38 MAPK. CONCLUSIONS: These findings demonstrate that LOX-1 expression in cardiac myocytes is induced by neurohormonal factors activated in heart failure and that LOX-1-dependent apoptosis in these cells requires p38 MAPK, a component of oxidant stress-sensitive signaling pathways.
|
Authors | E Iwai-Kanai, K Hasegawa, T Sawamura, M Fujita, T Yanazume, S Toyokuni, S Adachi, Y Kihara, S Sasayama |
Journal | Circulation
(Circulation)
Vol. 104
Issue 24
Pg. 2948-54
(Dec 11 2001)
ISSN: 1524-4539 [Electronic] United States |
PMID | 11739311
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Endothelin-1
- Enzyme Inhibitors
- FR 167653
- Imidazoles
- OLR1 protein, rat
- Pyrazoles
- Pyridines
- Receptors, LDL
- Receptors, Oxidized LDL
- Scavenger Receptors, Class E
- Mitogen-Activated Protein Kinases
- p38 Mitogen-Activated Protein Kinases
- SB 203580
- Norepinephrine
|
Topics |
- Animals
- Animals, Newborn
- Apoptosis
(physiology)
- Cells, Cultured
- Endothelin-1
(pharmacology)
- Enzyme Activation
(drug effects)
- Enzyme Inhibitors
(pharmacology)
- Heart Failure
(metabolism)
- Heart Ventricles
(cytology, drug effects, metabolism)
- Imidazoles
(pharmacology)
- Immunohistochemistry
- In Situ Nick-End Labeling
- Intracellular Membranes
(physiology)
- Membrane Potentials
(physiology)
- Mitochondria
(physiology)
- Mitogen-Activated Protein Kinases
(antagonists & inhibitors, metabolism)
- Norepinephrine
(pharmacology)
- Oxidative Stress
(physiology)
- Pyrazoles
(pharmacology)
- Pyridines
(pharmacology)
- Rats
- Rats, Inbred Dahl
- Receptors, LDL
(biosynthesis, genetics, physiology)
- Receptors, Oxidized LDL
- Scavenger Receptors, Class E
- Signal Transduction
(physiology)
- Transfection
- p38 Mitogen-Activated Protein Kinases
|